Skip to content

Gross Profit at other companies

Baxter International logo
Baxter InternationalBAX
$891M+3.5%
ADMA Biologics logo
ADMA BiologicsADMA
$80.75M+32.2%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$7.76M+51.1%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$296.4M+27.8%
Labcorp Holdings logo
Labcorp HoldingsLH
$1.01B+6.9%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$151.04M+7.1%

Other financials

Income statement

See full
Revenue$23.2M-36.4%
Operating income-$4.7M
Net income-$15.0M-1,206%
EPS (diluted)-$0.43-1,333%

Balance sheet

See full
Cash & equivalents$20.8M+152%
Total debt$156.9M+1,310%
Total equity-$28.4M-2,229%
Total assets$225.5M-5.8%

Cash flow

See full
Operating cash flow$4.7M
CapEx$1.1M-46.7%
Free cash flow$3.6M

Valuation

See full
Market cap$196.92M-35.4%
Enterprise value$333.06M+8.3%
P/S1.6×+0.5×

Profitability

See full
Gross margin31.3%-1.4pp
Operating margin-14.5%-2.2pp
Net margin-30%
FCF margin-36.4%

Returns & leverage

See full
Return on equity-612.1%
Debt / equity8.3×-1.5×
Current ratio3.8×+0.9×

Where this comes from

Calculated from Lifecore Biomedical, Inc.’s reported figures.

The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s gross profit?
Lifecore Biomedical, Inc. (LFCR) reported gross profit of $4.46M in Q1 2026.
How has Lifecore Biomedical, Inc.'s gross profit changed year-over-year?
Lifecore Biomedical, Inc.'s gross profit decreased by 68.1% year-over-year, from $13.98M to $4.46M.
What is the long-term trend for Lifecore Biomedical, Inc.'s gross profit?
Over 3 years (2022 to 2025), Lifecore Biomedical, Inc.'s gross profit has grown at a 1.0% compound annual growth rate (CAGR), from $39.07M to $40.3M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.